Skip to main content
Top
Published in: AIDS and Behavior 4/2012

01-05-2012 | Original Paper

HIV Transmission Rate Modeling: A Primer, Review, and Extension

Author: Steven D. Pinkerton

Published in: AIDS and Behavior | Issue 4/2012

Login to get access

Abstract

Several mathematical modeling studies based on the concept of “HIV transmission rates” have recently appeared in the literature. The transmission rate for a particular group of HIV-infected persons is defined as the mean number of secondary infections per member of the group per unit time. This article reviews the fundamental principles and mathematics of transmission rate models; explicates the relationship between these models, Bernoullian models of HIV transmission, and mathematical models based on the concept of the “reproductive rate of infection”; describes an extension of existing transmission rate models to better incorporate the positive impact of HIV treatment; and discusses the limitations of the transmission rate modeling approach. Results from the extended transmission rate model indicate that approximately 51.6% of new sexually-transmitted infections in the US are due to the transmission risk behaviors of infected persons who are unaware of their infection, including 10.9% due to persons in the acute phase of HIV infection. Findings from this study suggest that significant reductions in HIV incidence likely will require a combination of increased antibody testing, enhanced early detection of acute HIV infection, appropriate medical care and antiretroviral medicine adherence counseling, and behavioral risk reduction interventions.
Literature
1.
go back to reference Holtgrave DR. Estimation of annual HIV transmission rates in the United States, 1978–2000. J Acquir Immune Defic Synd. 2004;35:89–92.CrossRef Holtgrave DR. Estimation of annual HIV transmission rates in the United States, 1978–2000. J Acquir Immune Defic Synd. 2004;35:89–92.CrossRef
2.
go back to reference Holtgrave DR, Pinkerton SD. Can increasing awareness of HIV seropositivity reduce infections by 50% in the United States? J Acquir Immune Defic Synd. 2007;44:360–3.CrossRef Holtgrave DR, Pinkerton SD. Can increasing awareness of HIV seropositivity reduce infections by 50% in the United States? J Acquir Immune Defic Synd. 2007;44:360–3.CrossRef
3.
go back to reference Centers for Disease Control and Prevention. HIV surveillance—United States, 1981–2008. Morbid Mortal Wkly Rep. 2011;60:689–93. Centers for Disease Control and Prevention. HIV surveillance—United States, 1981–2008. Morbid Mortal Wkly Rep. 2011;60:689–93.
4.
go back to reference Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300:520–9.PubMedCrossRef Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300:520–9.PubMedCrossRef
5.
go back to reference Holtgrave DR, Hall HI, Rhodes PH, et al. Updated annual HIV transmission rates in the United States, 1978–2006. J Acquir Immune Defic Synd. 2009;50:236–8.CrossRef Holtgrave DR, Hall HI, Rhodes PH, et al. Updated annual HIV transmission rates in the United States, 1978–2006. J Acquir Immune Defic Synd. 2009;50:236–8.CrossRef
6.
go back to reference Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447–50.PubMedCrossRef Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447–50.PubMedCrossRef
7.
go back to reference Pinkerton SD. How many sexually-acquired HIV infections in the US are due to acute-phase HIV transmission? AIDS. 2007;21:1625–9.PubMedCrossRef Pinkerton SD. How many sexually-acquired HIV infections in the US are due to acute-phase HIV transmission? AIDS. 2007;21:1625–9.PubMedCrossRef
8.
go back to reference Prabhu VS, Hutchinson AB, Farnham PG, et al. Sexually acquired HIV in the United States due to acute-phase HIV transmission: An update. AIDS. 2009;23:1792–4.PubMedCrossRef Prabhu VS, Hutchinson AB, Farnham PG, et al. Sexually acquired HIV in the United States due to acute-phase HIV transmission: An update. AIDS. 2009;23:1792–4.PubMedCrossRef
9.
go back to reference Pinkerton SD, Holtgrave DR, Galletly CL. Infections prevented by increasing HIV serostatus awareness in the U.S., 2001 to 2004. J Acquir Immune Defic Synd. 2008;47:354–7.CrossRef Pinkerton SD, Holtgrave DR, Galletly CL. Infections prevented by increasing HIV serostatus awareness in the U.S., 2001 to 2004. J Acquir Immune Defic Synd. 2008;47:354–7.CrossRef
10.
go back to reference Hall HI, Green TA, Wolitski RJ, et al. Estimated HIV prevalence, incidence, and potential infections averted in the United States: A multiple scenario analysis. J Acquir Immune Defic Synd. 2010;55:271–6.CrossRef Hall HI, Green TA, Wolitski RJ, et al. Estimated HIV prevalence, incidence, and potential infections averted in the United States: A multiple scenario analysis. J Acquir Immune Defic Synd. 2010;55:271–6.CrossRef
11.
go back to reference Hutchinson AB, Patel P, Sansom SL, Farnham PG, Sullivan TJ, Bennett B, et al. Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings. PLoS Med. 2010;7:e1000342. doi:10.1371/journal.pmed.1000342. Hutchinson AB, Patel P, Sansom SL, Farnham PG, Sullivan TJ, Bennett B, et al. Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings. PLoS Med. 2010;7:e1000342. doi:​10.​1371/​journal.​pmed.​1000342.
12.
go back to reference Pinkerton SD, Kibicho JW, Galletly CL. Is the US AIDS Drug Assistance Program cost-effective? Under review. Pinkerton SD, Kibicho JW, Galletly CL. Is the US AIDS Drug Assistance Program cost-effective? Under review.
13.
go back to reference Holtgrave DR, Anderson T. Utilizing HIV transmission rates to assist in prioritizing HIV prevention services. Int J STD AIDS. 2004;15:789–92.PubMedCrossRef Holtgrave DR, Anderson T. Utilizing HIV transmission rates to assist in prioritizing HIV prevention services. Int J STD AIDS. 2004;15:789–92.PubMedCrossRef
14.
go back to reference Holtgrave DR. Potential and limitations of a ‘test and treat’ strategy as HIV prevention in the United States. Int J Clin Pract. 2010;64:678–81.PubMedCrossRef Holtgrave DR. Potential and limitations of a ‘test and treat’ strategy as HIV prevention in the United States. Int J Clin Pract. 2010;64:678–81.PubMedCrossRef
15.
go back to reference Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Morbid Mortal Wkly Rep. 2006;55(RR-14):1–16. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Morbid Mortal Wkly Rep. 2006;55(RR-14):1–16.
16.
go back to reference Fenton KA. Changing epidemiology of HIV/AIDS in the United States: implications for enhancing and promoting HIV testing strategies. Clin Infect Dis. 2007;45(suppl. 4):S213–20.PubMedCrossRef Fenton KA. Changing epidemiology of HIV/AIDS in the United States: implications for enhancing and promoting HIV testing strategies. Clin Infect Dis. 2007;45(suppl. 4):S213–20.PubMedCrossRef
17.
go back to reference El-Sadr W, Affrunti M, Gamble T, Zerbe A. Antiretroviral therapy: A promising HIV prevention strategy? J Acquir Immune Defic Synd. 2010;55(suppl. 2):S116–21.CrossRef El-Sadr W, Affrunti M, Gamble T, Zerbe A. Antiretroviral therapy: A promising HIV prevention strategy? J Acquir Immune Defic Synd. 2010;55(suppl. 2):S116–21.CrossRef
18.
go back to reference Lansky A, Brooks JT, DiNenno E, et al. Epidemiology of HIV in the United States. J Acquir Immune Defic Synd. 2010;55(suppl. 2):S64–8.CrossRef Lansky A, Brooks JT, DiNenno E, et al. Epidemiology of HIV in the United States. J Acquir Immune Defic Synd. 2010;55(suppl. 2):S64–8.CrossRef
19.
go back to reference Millett GA, Crowley JS, Koh H, et al. A way forward: The National HIV/AIDS Strategy and reducing HIV incidence in the United States. J Acquir Immune Defic Synd. 2010;55(suppl. 2):S144–7.CrossRef Millett GA, Crowley JS, Koh H, et al. A way forward: The National HIV/AIDS Strategy and reducing HIV incidence in the United States. J Acquir Immune Defic Synd. 2010;55(suppl. 2):S144–7.CrossRef
20.
go back to reference Pinkerton SD, Abramson PR. An alternative model of the reproductive rate of HIV infection: formulation, evaluation, and implications for risk reduction interventions. Evaluation Rev. 1994;18:371–88.CrossRef Pinkerton SD, Abramson PR. An alternative model of the reproductive rate of HIV infection: formulation, evaluation, and implications for risk reduction interventions. Evaluation Rev. 1994;18:371–88.CrossRef
21.
go back to reference Pinkerton SD, Abramson PR, Kalichman SC, et al. Secondary HIV transmission rates in a mixed-gender sample. Int J STD AIDS. 2000;11:38–44.PubMedCrossRef Pinkerton SD, Abramson PR, Kalichman SC, et al. Secondary HIV transmission rates in a mixed-gender sample. Int J STD AIDS. 2000;11:38–44.PubMedCrossRef
22.
go back to reference Pinkerton SD, Abramson PR. The Bernoulli-process model of HIV transmission: applications and implications. In: Holtgrave R, editor. Handbook of Economic Evaluation of HIV Prevention Programs. New York: Plenum Press; 1998. p. 13–32. Pinkerton SD, Abramson PR. The Bernoulli-process model of HIV transmission: applications and implications. In: Holtgrave R, editor. Handbook of Economic Evaluation of HIV Prevention Programs. New York: Plenum Press; 1998. p. 13–32.
23.
go back to reference Allard R. A mathematical model to describe the risk of infection from sharing injection equipment. J Acquir Immune Defic Synd. 1990;3:1010–6. Allard R. A mathematical model to describe the risk of infection from sharing injection equipment. J Acquir Immune Defic Synd. 1990;3:1010–6.
24.
25.
go back to reference Holtgrave DR. Is the elimination of HIV infection within reach in the United States? Lessons from an epidemiologic transmission model. Public Health Rep. 2010;125:372–6.PubMed Holtgrave DR. Is the elimination of HIV infection within reach in the United States? Lessons from an epidemiologic transmission model. Public Health Rep. 2010;125:372–6.PubMed
26.
go back to reference Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301:2380–2.PubMedCrossRef Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301:2380–2.PubMedCrossRef
27.
go back to reference Marks G, Crepaz N, Senterfitt W, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States. J Acquir Immune Defic Synd. 2005;39:446–53.CrossRef Marks G, Crepaz N, Senterfitt W, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States. J Acquir Immune Defic Synd. 2005;39:446–53.CrossRef
28.
go back to reference Cohen MS. HIV treatment as prevention: to be or not to be? J Acquir Immune Defic Synd. 2010;55:137–8.CrossRef Cohen MS. HIV treatment as prevention: to be or not to be? J Acquir Immune Defic Synd. 2010;55:137–8.CrossRef
Metadata
Title
HIV Transmission Rate Modeling: A Primer, Review, and Extension
Author
Steven D. Pinkerton
Publication date
01-05-2012
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2012
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-0042-8

Other articles of this Issue 4/2012

AIDS and Behavior 4/2012 Go to the issue